黄芪甲苷

有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
A111275-20mg
20mg 现货 Stock Image
A111275-100mg
100mg 现货 Stock Image
A111275-500mg
500mg 现货 Stock Image
A111275-2.5g
2.5g 现货 Stock Image

基本描述

别名 黄芪甲甙
英文别名 Astragaloside A | AKOS025311424 | AKOS027470287 | CCG-270470 | HMS3885E12 | Astrasieversianin XIV | s3901 | (2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethy
规格或纯度 分析标准品, ≥98%
英文名称 Astragaloside IV
生化机理 消炎。
应用 黄芪化学成分的研究
运输条件 常规运输
产品介绍

黄芪化学成分的研究

AI解读

关联靶点(人)

HepG2 (196354 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID

关联靶点(其它种属)

Mus musculus (284745 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Rattus norvegicus (775804 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Hepatitis B virus (7925 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Duck hepatitis B virus (235 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Pulmonary artery (4 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

名称和识别符

PubChem SID 504767538
分子类型 小分子
IUPAC Name (2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
INCHI InChI=1S/C41H68O14/c1-35(2)24(54-33-29(48)26(45)20(44)17-51-33)9-11-41-18-40(41)13-12-37(5)31(39(7)10-8-25(55-39)36(3,4)50)19(43)15-38(37,6)23(40)14-21(32(35)41)52-34-30(49)28(47)27(46)22(16-42)53-34/h19-34,42-50H,8-18H2,1-7H3/t19-,20+,21-,22+,23-,24-,25-,26-,27+,28-,29+,30+,31-,32-,33-,34+,37+,38-,39+,40-,41+/m0/s1
InChi Key QMNWISYXSJWHRY-YLNUDOOFSA-N
Canonical SMILES CC1(C(CCC23C1C(CC4C2(C3)CCC5(C4(CC(C5C6(CCC(O6)C(C)(C)O)C)O)C)C)OC7C(C(C(C(O7)CO)O)O)O)OC8C(C(C(CO8)O)O)O)C
Isomeric SMILES C[C@]12CC[C@@]34C[C@@]35CC[C@@H](C([C@@H]5[C@H](C[C@H]4[C@@]1(C[C@@H]([C@@H]2[C@]6(CC[C@H](O6)C(C)(C)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)(C)C)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O
WGK Germany 3
PubChem CID 13943297
分子量 784.97

化学和物理性质

密度 1.39
熔点 295-296°C
分子量 785.000 g/mol
XLogP3 1.300
氢键供体数Hydrogen Bond Donor Count 9
氢键受体数Hydrogen Bond Acceptor Count 14
可旋转键计数Rotatable Bond Count 7
精确质量Exact Mass 784.461 Da
单同位素质量Monoisotopic Mass 784.461 Da
拓扑极表面积Topological Polar Surface Area 228.000 Ų
重原子数Heavy Atom Count 55
形式电荷Formal Charge 0
复杂度Complexity 1460.000
同位素原子数Isotope Atom Count 0
定义的原子立体中心计数Defined Atom Stereocenter Count 21
未定义的原子立体中心计数Undefined Atom Stereocenter Count 0
定义的键立体中心计数Defined Bond Stereocenter Count 0
未定义的键立体中心计数Undefined Bond Stereocenter Count 0
所有立体化学键的总数The total count of all stereochemical bonds 0
共价键合单元计数Covalently-Bonded Unit Count 1

安全和危险性(GHS)

WGK Germany 3
个人防护装备 Eyeshields,Gloves,type N95 (US),type P1 (EN143) respirator filter

技术规格说明书

Purity(HPLC) 98-100(%)
Melting point 295-296(℃)
Appearance(A111275) Colorless or White Powder
Mass spectrum Conforms to standard

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到10个结果

批号(Lot Number) 证书类型 日期 货号
A2329160 分析证书 24-11-20 A111275
A2329165 分析证书 24-11-20 A111275
J2430702 分析证书 24-11-05 A111275
E2217033 分析证书 24-02-05 A111275
E2217036 分析证书 24-02-05 A111275
E2217037 分析证书 24-02-05 A111275
E2217042 分析证书 24-02-05 A111275
L2007265 分析证书 22-09-20 A111275
L2007264 分析证书 22-09-20 A111275
L2007263 分析证书 22-09-20 A111275

此产品的引用文献

1. Chan-juan Chai, Yao Sun, Rui-fang Chi, Hui-yu Yang, Bin Yang, Bao Li.  (2024)  Astragaloside IV alleviates LPS-induced cardiomyocyte hypertrophy and collagen expression associated with CCL2-mediated activation of NF-κB signaling pathway.  BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,  693  (149367).  [PMID:38091841] [10.1016/j.bbrc.2023.149367]
2. Xin Zhao, Jinlong Luo, Ying Huang, Lei Mu, Jueying Chen, Zhen Liang, Zhanhai Yin, Dake Chu, Yong Han, Baolin Guo.  (2023)  Injectable Antiswelling and High-Strength Bioactive Hydrogels with a Wet Adhesion and Rapid Gelling Process to Promote Sutureless Wound Closure and Scar-free Repair of Infectious Wounds.  ACS Nano,  17  (21): (22015–22034).  [PMID:37862553] [10.1021/acsnano.3c08625]
3. Qing Xu, Dekun Li, Meixu Wan, Yanxin Zhang, Zhi Li, Aichun Ju.  (2023)  An Online CMC–LC/MS Method for Screening Angiogenesis Promoting Components in Yiqi Fumai Lyophilization Injection (YQFM).  Natural Product Communications,  [10.1177/1934578X231182209]
4. Tianshu Chu, Qingye Li, Chun Dai, Xiang Li, Xiang Kong, Yangming Fan, Hongyan Yin, Jianjun Ge.  (2023)  A novel Nanocellulose-Gelatin-AS-IV external stent resists EndMT by activating autophagy to prevent restenosis of grafts.  Bioactive Materials,  22  (466).  [PMID:36330163] [10.1016/j.bioactmat.2022.10.013]
5. Xiaoyu Zhu, Fangze Tao, Li Zhang, Yajie Yu, Yanchao Xu, Gang Yang, Zhifeng Wei, Yidong Cheng, Xuelai Yin, Xinyuan Zhang, Wu Wei, Anxi Wang.  (2022)  Astragaloside IV Protects Detrusor from Partial Bladder Outlet Obstruction-Induced Oxidative Stress by Activating Mitophagy through AMPK-ULK1 Pathway.  Oxidative Medicine and Cellular Longevity,  2022  (5757367).  [PMID:35873803] [10.1155/2022/5757367]
6. Xiaowei Wang, Yufen Li, Ji Li, Yaxuan Gu, Lihong Sang, Dongkai Wang.  (2021)  NIR stimulus-responsive AstragalosideIV-Indocyanin green liposomes for chemo-photothermal therapy.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,  64  (102257).  [10.1016/j.jddst.2020.102257]
7. Dongyu Xie, Ping Zhou, Lin Liu, Wenjing Jiang, Haina Xie, Liang Zhang, Donghao Xie.  (2019)  Protective Effect of Astragaloside IV on Hepatic Injury Induced by Iron Overload.  Biomed Research International,  2019  (3103946).  [PMID:31428632] [10.1155/2019/3103946]
8. Jiamao Lin, Lijun Fang, Hui Li, Zhenxiang Li, Linmao Lyu, Haiyong Wang, Jun Xiao.  (2019)  Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress.  EUROPEAN JOURNAL OF PHARMACOLOGY,  859  (172490).  [PMID:31229536] [10.1016/j.ejphar.2019.172490]
9. Lu Jianrao, Yi Yang, Pan Ronghua, Zhang Chuanfu, Han Haiyan, Chen Jie, Liu Wenrui.  (2018)  Berberine protects HK-2 cells from hypoxia/reoxygenation induced apoptosis via inhibiting SPHK1 expression.  Journal of Natural Medicines,  72  (2): (390-398).  [PMID:29260413] [10.1007/s11418-017-1152-z]

参考文献

1. Chan-juan Chai, Yao Sun, Rui-fang Chi, Hui-yu Yang, Bin Yang, Bao Li.  (2024)  Astragaloside IV alleviates LPS-induced cardiomyocyte hypertrophy and collagen expression associated with CCL2-mediated activation of NF-κB signaling pathway.  BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,  693  (149367).  [PMID:38091841] [10.1016/j.bbrc.2023.149367]
2. Xin Zhao, Jinlong Luo, Ying Huang, Lei Mu, Jueying Chen, Zhen Liang, Zhanhai Yin, Dake Chu, Yong Han, Baolin Guo.  (2023)  Injectable Antiswelling and High-Strength Bioactive Hydrogels with a Wet Adhesion and Rapid Gelling Process to Promote Sutureless Wound Closure and Scar-free Repair of Infectious Wounds.  ACS Nano,  17  (21): (22015–22034).  [PMID:37862553] [10.1021/acsnano.3c08625]
3. Qing Xu, Dekun Li, Meixu Wan, Yanxin Zhang, Zhi Li, Aichun Ju.  (2023)  An Online CMC–LC/MS Method for Screening Angiogenesis Promoting Components in Yiqi Fumai Lyophilization Injection (YQFM).  Natural Product Communications,  [10.1177/1934578X231182209]
4. Tianshu Chu, Qingye Li, Chun Dai, Xiang Li, Xiang Kong, Yangming Fan, Hongyan Yin, Jianjun Ge.  (2023)  A novel Nanocellulose-Gelatin-AS-IV external stent resists EndMT by activating autophagy to prevent restenosis of grafts.  Bioactive Materials,  22  (466).  [PMID:36330163] [10.1016/j.bioactmat.2022.10.013]
5. Xiaoyu Zhu, Fangze Tao, Li Zhang, Yajie Yu, Yanchao Xu, Gang Yang, Zhifeng Wei, Yidong Cheng, Xuelai Yin, Xinyuan Zhang, Wu Wei, Anxi Wang.  (2022)  Astragaloside IV Protects Detrusor from Partial Bladder Outlet Obstruction-Induced Oxidative Stress by Activating Mitophagy through AMPK-ULK1 Pathway.  Oxidative Medicine and Cellular Longevity,  2022  (5757367).  [PMID:35873803] [10.1155/2022/5757367]
6. Xiaowei Wang, Yufen Li, Ji Li, Yaxuan Gu, Lihong Sang, Dongkai Wang.  (2021)  NIR stimulus-responsive AstragalosideIV-Indocyanin green liposomes for chemo-photothermal therapy.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,  64  (102257).  [10.1016/j.jddst.2020.102257]
7. Dongyu Xie, Ping Zhou, Lin Liu, Wenjing Jiang, Haina Xie, Liang Zhang, Donghao Xie.  (2019)  Protective Effect of Astragaloside IV on Hepatic Injury Induced by Iron Overload.  Biomed Research International,  2019  (3103946).  [PMID:31428632] [10.1155/2019/3103946]
8. Jiamao Lin, Lijun Fang, Hui Li, Zhenxiang Li, Linmao Lyu, Haiyong Wang, Jun Xiao.  (2019)  Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress.  EUROPEAN JOURNAL OF PHARMACOLOGY,  859  (172490).  [PMID:31229536] [10.1016/j.ejphar.2019.172490]
9. Lu Jianrao, Yi Yang, Pan Ronghua, Zhang Chuanfu, Han Haiyan, Chen Jie, Liu Wenrui.  (2018)  Berberine protects HK-2 cells from hypoxia/reoxygenation induced apoptosis via inhibiting SPHK1 expression.  Journal of Natural Medicines,  72  (2): (390-398).  [PMID:29260413] [10.1007/s11418-017-1152-z]

溶液计算器